IL6 and acute respiratory distress syndrome: DPP-4 inhibition has been shown to attenuate lipopolysaccharide-induced lung injury in murine models of ARDS and to inhibit the release of TNF-α, IL-6 and IL-8 by human lung microvascular endothelial cells [70].